
This episode discusses bowel cancer in New Zealand, focusing on the lack of funded drugs and the high costs associated with treatment. Key statistics reveal that bowel cancer is the second leading cause of cancer deaths in the country, with over 9,500 annual cancer fatalities.
The conversation highlights the frustration surrounding the absence of new funded drugs for over 20 years, leaving many patients unable to afford necessary treatments that can cost up to 60,000 NZD per year. The impact of health insurance limitations is also addressed.
Listeners learn about the alarming cancer rates in New Zealand, which are among the highest per population, raising questions about healthcare accessibility and the effectiveness of current policies.
Bowel cancer in New Zealand faces funding issues, leading to high death rates and unaffordable treatments.

This episode stands out for the following: